medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2013, Número 3

<< Anterior Siguiente >>

Ann Hepatol 2013; 12 (3)


Analysis of hepatitis C virus (HCV) RNA load in platelets of HCV-monoinfected patients receiving antiviral therapy

do Espírito-Santo MP, Brandão-Mello CE, Alves MV, Lampe E, De Almeida AJ

Idioma: Ingles.
Referencias bibliográficas: 32
Paginas: 373-379
Archivo PDF: 103.73 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Ramos-Casals M, Font J. Extrahepatic manifestations in patients with chronic hepatitis C virus infection. Curr Opin Rheumatol 2005; 17: 447-55.

  2. De Almeida AJ, Campos-de-Magalhães M, Brandão-Mello CE, de Oliveira RV, Yoshida CF, Lampe E. Detection of hepatitis C virus in platelets: evaluating its relationship to host and viral factors. Hepatogastroenterology 2007; 54: 964-8.

  3. De Almeida AJ, Campos-de-Magalhães M, de Melo Marçal OP, Brandão-Mello CE, Okawa MY, de Oliveira RV, do Espírito- Santo MP, et al. Hepatitis C virus-associated thrombocytopenia: a controlled prospective, virological study. Ann Hematol 2004; 83: 434-40.

  4. Hamaia S, Li C, Allain JP. The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines. Blood 2001; 98: 2293-300.

  5. Nagamine T, Ohtuka T, Takehara K, Arai T, Takagi H, Mori M. Thrombocytopenia associated with hepatitis C viral infection. J Hepatol 1996; 24: 135-40.

  6. Alter HJ. An unexpected link between HCV and platelets. Blood 2001; 98: 2291.

  7. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol 2011; 55: 245-64.

  8. Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009; 49: 1335-74.

  9. Carreño V, Pardo M, López-Alcorocho JM, Rodríguez-Iñigo E, Bartolomé J, Castillo I. Detection of hepatitis C virus (HCV) RNA in the liver of healthy, anti-HCV antibody-positive, serum HCV RNA-negative patients with normal alanine aminotransferase levels. J Infect Dis 2006; 194: 53-60.

  10. Castillo I, Pardo M, Bartolomé J, Ortiz-Movilla N, Rodríguez- Iñigo E, de Lucas S, Salas C et al. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. J Infect Dis 2004; 189: 7-14.

  11. Mohamad HI, El-Bab HK, Kamal AM. HCV RNA in serum and peripheral blood mononuclear cells after successful interferon therapy. Hepatogastroenterology 2011; 58: 932-6.

  12. De Almeida AJ, Campos-de-Magalhães M, Brandão-Mello CE, de Oliveira RV, do Espirito-Santo MP, Yoshida CF, Lampe E. Detection of hepatitis C virus in platelets: evaluating its relationship to antiviral therapy outcome. Hepatogastroenterology 2009; 56: 429-36.

  13. Kau A, Vermehren J, Sarrazin C. Treatment predictors of a sustained virologic response in hepatitis B and C. J Hepatol 2008; 49: 634-51.

  14. Colucci G, Ferguson J, Harkleroad C, Lee S, Romo D, Soviero S, Thompson J, et al. Improved COBAS TaqMan hepatitis C virus test (Version 2.0) for use with the High Pure system: enhanced genotype inclusivity and performance characteristics in a multisite study. J Clin Microbiol 2007; 45: 3595-600.

  15. Otto TD, Vasconcellos EA, Gomes LH, Moreira AS, Degrave WM, Mendonça-Lima L, Alves-Ferreira M. ChromaPipe: a pipeline for analysis, quality control and management for a DNA sequencing facility. Genet Mol Res 2008; 7: 861-71.

  16. Bedossa P, Poynard T. The METAVIR Cooperative Study Group. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996; 24: 289-93.

  17. Revie D, Salahuddin SZ. Human cell types important for hepatitis C virus replication in vivo and in vitro: old assertions and current evidence. Virol J 2011; 8: 346.

  18. Torres B, Martin JL, Caballero A, Villalobos M, Olea N. HCV in serum, peripheral blood mononuclear cells and lymphocyte subpopulations in C-hepatitis patients. Hepatol Res 2000; 18: 141-51.

  19. Trimoulet P, Bernard PH, de Ledinghen V, Oui B, Chene G, Saint-Marc Girardin MF, Dantin S, et al. Quantitation of hepatitis C virus RNA in plasma and peripheral blood mononuclear cells of patients with chronic hepatitis treated with interferon alpha. Dig Dis Sci 2000; 45: 175-81.

  20. Chary A, Winters MA, Eisen R, Knight TH, Asmuth DM, Holodniy M. Quantitation of hepatitis C virus RNA in peripheral blood mononuclear cells in HCV-monoinfection and HIV/ HCV-coinfection. J Med Virol 2012; 84: 431-7.

  21. Dahari H, Forns X, Neumann AU, Perelson AS. The extrahepatic contribution to HCV plasma viremia. J Hepatol 2006; 45: 626-7.

  22. Schubert P, Devine DV. De novo protein synthesis in mature platelets: a consideration for transfusion medicine. Vox Sang 2010; 99: 112-22.

  23. Schwertz H, Rowley JW, Tolley ND, Campbell RA, Weyrich AS. Assessing protein synthesis by platelets. Methods Mol Biol 2012; 788: 141-53.

  24. Weyrich AS, Schwertz H, Kraiss LW, Zimmerman GA. Protein synthesis by platelets: historical and new perspectives. J Thromb Haemost 2009; 7: 241-6.

  25. Agnello V, Ábel G, Knight GB, Monteverde A, Ballare M, Bertoncelli MC, Pileri SA. Detection of hepatitis C virus (HCV) in liver, bone marrow, and lymph nodes in type II mixed cryoglobulinemia (MC) using in situ hybridization [abstract C163]. Fifth International Symposium on Hepatitis C Virus and Related Viruses; 1995 Aug. 28-Sept. 3; Gold Coast, Australia.

  26. Bordin G, Ballaré M, Zigrossi P, Bertoncelli MC, Paccagnino L, Baroli A, Brambilla M, et al. A laboratory and thrombokinetic study of HCV-associated thrombocytopenia: a direct role of HCV in bone marrow exhaustion? Clin Exp Rheumatol 1995; 13: S39-S43.

  27. Li X, Jeffers LJ, Garon C, Fischer ER, Scheffel J, Moore B, Reddy KR et al. Persistence of hepatitis C virus in a human megakaryoblastic leukaemia cell line. J Viral Hepat 1999; 6: 107-14.

  28. Blackard JT, Smeaton L, Hiasa Y, Horiike N, Onji M, Jamieson DJ, Rodriguez I, et al. Detection of hepatitis C virus (HCV) in serum and peripheral-blood mononuclear cells from HCV-monoinfected and HIV/HCV-coinfected persons. J Infect Dis 2005; 192: 258-65.

  29. Minosse C, Calcaterra S, Abbate I, Selleri M, Zaniratti MS, Capobianchi MR. Possible compartmentalization of hepatitis C viral replication in the genital tract of HIV-1-coinfected women. J Infect Dis 2006; 194: 1529-36.

  30. Blackard JT, Ma G, Welge JA, Martin CM, Sherman KE, Taylor LE, Mayer KH, et al. Analysis of a non-structural gene reveals evidence of possible hepatitis C virus (HCV) compartmentalization. J Med Virol 2012; 84: 242-52.

  31. Inokuchi M, Ito T, Nozawa H, Miyashita M, Morikawa K, Uchikoshi M, Shimozuma Y, et al. Lymphotropic hepatitis C virus has an interferon-resistant phenotype. J Viral Hepat 2012; 19: 254-62.

  32. Espírito-Santo MP, de Almeida AJ, Lampe E. Detection and analysis of hepatitis C virus (HCV) quasispecies in platelets from antiviral therapy-naïve patients with chronic HCV infection. Virus Rev Res 2011; 16: 187-8.




2020     |     www.medigraphic.com